Last update : 07/10/2014 | Version : 1 | ID : 3988
General | |
Identification | |
Detailed name | PGRx: Acute Liver Damage |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | 908.025 |
General Aspects | |
Others (details) | Acute liver damage |
Keywords | Pharmacoepidemiology |
Scientific investigator(s) (Contact) | |
Name of the director | Grimaldi - Bensouda |
Surname | Lamiae |
Address | 10 place de Catalogne - 75014 Paris |
Phone | 01 55 42 53 00 |
contact@la-ser.com | |
Collaborations | |
Funding | |
Funding status |
Private |
Details | LA-SER |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | LA-SER |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Case control study |
Database recruitment is carried out by an intermediary |
A selection of health care professionals |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Cases of acute liver damage are recruited by a network of hepatology or gastroenterology centres and by referrals from a network of general practitioners located throughout the territory. |
Database objective | |
Main objective | Surveillance and assessment of the risk of liver damage from drug exposure during actual treatment. |
Inclusion criteria | Case subjects: patients, men or women over 18 years old, with acute liver damage confirmed by a specialist and followed-up for a maximum of 6 months before recruitment. Case-controls: patients (men and women over 18 years old) who have consulted a general practitioner |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
General population |
Gender |
Male Woman |
Geography area |
International |
Detail of the geography area | France, Germany |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2008 |
Size of the database | |
Size of the database (number of individuals) |
[10 000-20 000[ individuals |
Details of the number of individuals | - 60 cas/cases - 13000 témoins/controls |
Data | |
Database activity |
Current data collection |
Type of data collected |
Clinical data Declarative data |
Clinical data (detail) |
Direct physical measures |
Declarative data (detail) |
Phone interview |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity |
Procedures | |
Participant monitoring |
No |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://www.em-consulte.com/en/article/211579 |
Link to the document | http://www.em-consulte.com/en/article/211579 |
Link to the document | http://www.em-consulte.com/en/article/211579 |
Link to the document | http://www.em-consulte.com/en/article/211579 |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | To be defined |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05